CQS New City High Yield Fund Limited : Half-yearly report

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
161
CQS New City High Yield Fund Limited : Half-yearly report

Date:      6 March 2017 From:      CQS New City High Yield Fund Limited LEI:        549300KMGN75B0PTWT07 Subject: Interim Report

Unaudited statement of results for the six months ended 31 December 2016

Chairman's Statement

Highlights for the Six Months to 31 December 2016

  • Net asset value total return of 9.8%.
  • Ordinary share price total return of 8.1%.
  • Dividend yield of 7.4%, based on dividends at an annualised rate of 4.39 pence and a share price of 59.13 pence at 31 December 2016.
  • Ordinary share price at a premium of 2.9% to net asset value at 31 December 2016.
  • £1.0m of equity raised during the period.

Investment and Share Price Performance Your Company's net asset value increased by 5.1% to 57.5 pence per share during the six months ended 31 December 2016.  When this capital measure is adjusted for the payment of dividends totalling 1.96 pence per share in respect of the period, the net asset value total return was a strong 9.8%.  The share price total return for the same period was similarly strong at 8.1%,

Earnings and Dividends The Company declared two dividends of 0.98 pence in respect of the period, an increase of 0.1% on those declared in respect of the same period last year.  Based on an annualised rate of 4.39 pence and a share price of 61.25 pence at the time of writing, this represents a yield of 7.2%.

Gearing The Company renewed its existing £30m loan facility with Scotiabank in December 2016 at a current all-in rate of 1.27%.  The new facility is on comparable terms with the one that it replaced.  £25m was drawn down at 31 December 2016 and the Company had an effective gearing rate of 11%.

Rating and Fund Raising The market continued to attach a premium rating to the shares of your Company throughout the period under review.  £1.0m of new equity was issued during the period as part of the process of managing the premium to net asset value at which your Company's shares trade, something that the Board will continue to keep under close review.

Board I am delighted to welcome Ian Cadby, who joined us on 18 January 2017, to the Board. Ian, a Jersey resident, has over 27 years' experience within the financial services industry in London, New York and Jersey with a strong emphasis on risk management, corporate governance and board strategy. These are skills that further strengthen the Board's ability to steer your Company through the ever changing financial environment.

After a process of active refreshment, the Board is now at full strength with five Directors in total; three residing in Jersey and two in the UK.

Outlook We began the six months under review digesting the outcome of the Brexit vote, and we close it contemplating the early stages of the Trump presidency.  The first resulted in dramatic sterling weakness, a cut in UK interest rates and more quantitative easing. Equity markets were unexpectedly firm, and were buoyed further by the early news from the United States.  Our portfolio manager, Ian Francis, considers these matters at greater length in his Investment Manager's Review. High yield markets reacted well to the turbulence of the period under review, and the Manager continues to find value in the bond markets.  The strength of the US economy and the long awaited first increase in interest rates by the Federal Reserve point the way forward, and your Company remains well positioned to benefit from the prevailing market trends.

James G West Chairman, 3 March 2017

Investment Manager's Review

The second half of calendar year 2016, had all the potential for highly volatile markets and further political uncertainty. We started from a point just after the Brexit vote and the immediate devaluation of sterling and this would set the scene for the UK for the period.

In the UK, after a very surprising Conservative party leadership contest, the party rapidly chose Theresa May thus removing the opportunity for a summer of over hyped media coverage and political mudslinging. This removed a lot of uncertainty in UK equity and bond markets, but had, unsurprisingly no effect on sterling. The weakness of the currency would be a positive factor for the UK economy throughout the period. August saw the Bank of England step in with a 25 basis point cut in rates, a further £60bn of quantitative easing, £10bn of corporate bond purchases and £100m of funding for lending, all of which had the desired positive effect on markets with the high yield market reacting particularly well.

The United States economy showed continued strength of recovery which was evidenced by new home sales being up 12.4% (the most rapid rise since October 2007), and strong employment data, adding 151,000 jobs in August. This was all positive news and put pressure on the Federal Reserve Bank to raise rates.

Europe had some negative news in September, with the publishing of second quarter GDP data, which for France and Italy showed their economies stalling with growth at a mediocre 0.3%. Not that Germany provided much solace with a flat GDP figure of 0.3% which as Europe's largest economy was a worrying event.  We are still a long way from sustained recovery in Europe.

The United States economy continued to strengthen in front of the election evidenced by the median weekly earnings being up 3% year on year, when added to all of the positive figures elsewhere in the economy this would have normally triggered a rate rise, but in this case just ahead of a very acrimonious  election which was way too close to call at that point.

Well it happened. Donald Trump was elected by the US populous getting the majority in the electoral college, despite getting 3 million less votes than Hillary Clinton! This was a continuation of the western world's rebellion against the political establishment. The first impressions of a Trump presidency were an education, with various dictates from his Twitter account, including a couple which "encouraged" major auto manufacturers to cancel plans for expansion in Mexico and relocate the new plants into the United States.

Away from the politics a fully-fledged US economic recovery was confirmed when the Federal Reserve Bank finally raised rates by 25bp in early December followed by non-farm payroll productivity up 3.1% in the third quarter and unemployment down to 4.6% with 178,000 jobs created in November alone. The US equity markets took these along with a Trump presidency  as very bullish for the US going forward and raced to a new all-time high of 19,983.26 on the 20 th December.

In the UK, the Autumn statement from the Chancellor Phillip Hammond was an exercise in positioning of a government with an uncomfortably small majority. The Treasury was positioned as central to Brexit and he clipped the wings of 'Hard Brexiteers'  by taking a trick from private sector CFO's and kitchen sinking the figures placing the Governments economic and political options right in the middle of the worst case scenario zone. With the usual benefit that he will be able to take all the kudos that better performance brings. The FTSE100 was still focussed on exporters and the strength of equities in the United States and had a positive move into the end of December, whilst in fixed income markets all was much quieter with low volumes and not much volatility.

For the Company's portfolio the major transactions were switching out of Enterprise Inns 6.875% 2025 into Unique Pubs 7.385% 2024 to pick up yield and shorten duration. Taking profits in Old Mutual 8.875% 2025 and redeploying the proceeds into Partnership 9.5% 2025 and Permanent TSB 8.625% perpetual, we opened a holding in 1st Credit 11% 2020 below par.  This company has subsequently been bid for by Justicia Group and we would expect these bonds to be called once the deal goes through towards the end of the first quarter. We also increased our US$ exposure in the guise of Louis Dreyfus 8.25% perpetual and Trafigura 7.625% perpetual.

The equity element of the portfolio saw sales for Greencoat UK Wind, SQN Asset Finance and  NextEnergy Solar Fund as medium term investment targets were met. We also partially sold New River Retail downsizing the holding on a premium to NAV of 17% and a forecast yield of 5.9%.

We continue to look for opportunities in both bond and equity markets which meet the Company's requirements, we believe that the new issue market may offer some of these in both areas, and market volatility will continue to give a second chance to invest in some of the existing holdings which are currently too high to add to, or throw up new ones which we do not own.

The calendar year of 2017 has many political events ahead to provide such volatility. The continuing governing by Twitter by President Trump, the French presidential elections, German general elections, and of course Brexit negotiations will be giving plenty of headlines for the next two years.

Ian Francis New City Investment Managers 3 March 2017

Condensed Income Statement (Unaudited)

For the six months ended 31 December 2016

  Six months ended 31 December 2016
  Notes Revenue Capital Total
          £ '000       £'000       £'000
Capital gains on investments        
Gains on investments 3 - 10,022 10,022
Exchange gains   - 143 143
         
Revenue        
Income 4 10,077 - 10,077
Total income   10,077 10,165 20,242
         
Expenses        
Investment management fee 5 (679) (226) (905)
Other expenses   (338) (10) (348)
Total expenses   (1,017) (236) (1,253)
Profit before finance costs and taxation   9,060 9,929 18,989
         
Finance costs        
Interest payable and similar charges   (125) (42) (167)
Profit before taxation   8,935 9,887 18,822
         
Irrecoverable withholding tax   (132) - (132)
Profit after taxation   8,803 9,887 18,690
         
Earnings per ordinary share (pence) 6 2.42 2.72 5.14
         

The total column of this statement represents the Company's Income Statement, prepared in accordance with IFRS.  The supplementary revenue return and capital return columns are both prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in the above statement are derived from continuing operations.

No operations were acquired or discontinued during the period.

Condensed Income Statement (Unaudited)

For the six months ended 31 December 2015

  Six months ended 31 December 2015
  Notes Revenue Capital Total
          £ '000       £'000       £'000
Capital losses on investments        
Losses on investments 3 - (8,711) (8,711)
Exchange losses   - (6) (6)
         
Revenue        
Income 4 9,864 - 9,864
Total income   9,864 (8,717) 1,147
         
Expenses        
Investment management fee 5 (665) (222) (887)
Other expenses   (358) (34) (392)
Total expenses   (1,023) (256) (1,279)
Profit/(loss) before finance costs and taxation   8,841 (8,973) (132)
         
Finance costs        
Interest payable and similar charges   (157) (52) (209)
Profit/(loss) before taxation   8,684 (9,025) (341)
         
Irrecoverable withholding tax   (185) - (185)
Profit/(loss) after taxation   8,499 (9,025) (526)
         
Earnings per ordinary share (pence) 6 2.38 (2.53) (0.15)
         

The total column of this statement represents the Company's Income Statement, prepared in accordance with IFRS.  The supplementary revenue return and capital return columns are both prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in the above statement are derived from continuing operations.

No operations were acquired or discontinued during the period.

Condensed Income Statement (Audited)

For the year ended 30 June 2016

  Year ended 30 June 2016
  Notes Revenue Capital Total
          £'000       £'000       £'000
Capital losses on investments        
Losses on investments 3 - (14,281) (14,281)
Exchange gains   - 75 75
         
Revenue        
Income 4 18,692 - 18,692
Total income   18,692 (14,206) 4,486
         
Expenses        
Investment management fee 5 (1,328) (443) (1,771)
Other expenses   (653) (61) (714)
Total expenses   (1,981) (504) (2,485)
Profit/(loss) before finance costs and taxation   16,711 (14,710) 2,001
         
Finance costs        
Interest receivable   1 - 1
Interest payable and similar charges   (295) (98) (343)
Profit/(loss) before taxation   16,417 (14,808) 1,609
         
Irrecoverable withholding tax   (261) - (261)
Profit/(loss) after taxation   16,156 (14,808) 1,348
         
Earnings per ordinary share (pence) 6 4.50 (4.12) 0.38
         

The total column of this statement represents the Company's Income Statement, prepared in accordance with IFRS.  The supplementary revenue return and capital return columns are both prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in the above statement are derived from continuing operations.

No operations were acquired or discontinued during the year.

Condensed Balance Sheet

As at 31 December 2016

    As at As at As at
    31 December 2016 31 December 2015 30 June 2016
  Notes (unaudited) (unaudited) (audited)
    £'000 £'000 £'000
Non-current assets        
Investments held at fair value   227,389 218,896 211,882
Current assets        
Other receivables   4,953 4,412 3,952
Cash and cash equivalents   1,626 4,878 8,201
    6,579 9,290 12,153
Total assets   233,968 228,186 224,035
         
Current liabilities        
Bank loan facility 7 (25,000) (25,000) (25,000)
Other payables   (246) (214) (1,208)
Total liabilities   (25,246) (25,214) (26,208)
Net assets   208,722 202,972 197,827
         
Stated capital and reserves        
Stated capital account   155,410 154,398 154,397
Special distributable reserve   50,385 50,385 50,385
Capital reserve   (12,438) (16,800) (22,325)
Revenue reserve   15,365 14,989 15,370
Equity shareholders' funds   208,722 202,972 197,827
         
Net asset value per ordinary share (pence) 9 57.47 56.86 54.68
         

Statement of Changes in Equity

For the six months ended 31 December 2016 (unaudited)

    Stated Special      
    capital distributable Capital Revenue  
    account reserve reserve reserve Total
  Notes £'000 £'000 £'000 £'000 £'000
             
At 1 July 2016   154,397 50,385 (22,325) 15,370 197,827
Total comprehensive income for the period:            
Profit for the period   - - 9,887 8,803 18,690
Transactions with shareholders recognised directly in equity:            
Dividends paid 2 - - - (8,808) (8,808)
Issue of shares   1,013 - - - 1,013
At 31 December 2016   155,410 50,385 (12,438) 15,365 208,722
             

For the six months ended 31 December 2015 (unaudited)

    Stated Special      
    capital distributable Capital Revenue  
    account reserve reserve reserve Total
  Notes £'000 £'000 £'000 £'000 £'000
             
At 1 July 2015   150,963 50,385 (7,775) 15,103 208,676
Total comprehensive income for the period:            
(Loss)/Profit for the period   - - (9,025) 8,499 (526)
Transactions with shareholders recognised directly in equity:            
Dividends paid 2 - - - (8,613) (8,613)
Issue of shares   3,435 - - - 3,435
At 31 December 2015   154,398 50,385 (16,800) 14,989 202,972

For the year ended 30 June 2016 (audited)

    Stated Special      
    capital distributable Capital Revenue  
    Account reserve reserve reserve Total
  Notes £'000 £'000 £'000 £'000 £'000
             
At 1 July 2015   150,963 50,385 (7,775) 15,103 208,676
Total comprehensive income for the year:            
(Loss)/Profit for the year   - - (14,808) 16,156 1,348
Reserve transfer   - - 258 (258) -
Transactions with owners recognised directly in equity:            
Dividends paid 2 - - - (15,631) (15,631)
Issue of shares   22,825 - - - 22,825
Buyback of ordinary shares for Treasury   (19,391) - - - (19,391)
At 30 June 2016   154,397 50,385 (22,325) 15,370 197,827
             

Cash Flow Statement

For the six months ended 31 December 2016

  Six months Six months  
  ended ended Year ended
  31 December 2016 (unaudited) 31 December 2015 (unaudited) 30 June 2016 (audited)
  £'000 £'000 £'000
       
Operating activities      
Profit before finance costs and taxation 18,989 (132) 2,001
(Gains)/losses on investments (10,022) 8,711 14,281
Effective yield (414) (363) (625)
Exchange (gains)/losses (143) 6 (75)
Increase in other receivables (1,001) (869) (409)
(Decrease)/increase in other payables (10) (4) 31
       
Net cash inflow from operating activities before interest and taxation   7,399   7,349   15,204
Interest received - - 1
Interest paid (167) (209) (371)
Irrecoverable withholding tax paid (132) (185) (261)
Net cash inflow from operating activities 7,100 6,955 14,567
       
Investing activities      
Purchases of investments (35,807) (35,373) (65,791)
Sales of investments 30,735 30,294 62,410
Net cash outflow from investing activities (5,072) (5,079) (3,381)
       
Financing activities      
Equity dividends paid (8,808) (8,613) (15,631)
Drawdown of bank loan facility - 2,000 2,000
Issue of ordinary shares 1,013 3,435 3,434
Net cash outflow from financing activities (7,795) (3,178) (10,197)
       
(Decrease)/increase in cash and cash equivalents (5,767) (1,302) 989
Cash and cash equivalents at the start of the period 8,201 6,220 6,220
Movement on bank overdraft (951) (34) 951
Cashflow (5,767) (1,302) 989
Exchange gains/(losses) 143 (6) 75
Cash and cash equivalents at the end of the period* 1,626 4,878 8,201
       

*Net debt includes cash held at bank and bank loan facility. Notes to the Accounts

  1. Basis of Preparation

The unaudited interim results which cover the six month period to 31 December 2016 have been prepared in accordance with International Accounting Standard ('IAS') 34 - 'Interim Financial Reporting', and the accounting polices as set out in the statutory accounts of the Company for the year ended 30 June 2016.

Going concern The condensed consolidated financial statements have been prepared on the going concern basis.  In assessing the going concern basis of accounting the Directors have had regard to the guidance issued by the Financial Reporting Council.  After making enquiries and bearing in mind the nature of the Company's business and assets, the Directors consider that the Company has adequate resources to continue in operational existence for the foreseeable future.  For this reason, they continue to adopt the going concern basis in preparing the financial statements.

2.     Dividends

Amounts recognised as distributions to equity holders in the period:

  Six months ended 31 December 2016 Six months ended 31 December 2015         Year ended       30 June 2016
 
    Rate   Rate   Rate
  £'000 (pence) £'000 (pence) £'000 (pence)
In respect of the previous period:            
Fourth interim dividend 5,246 1.45 5,161 1.45 5,161 1.45
             
In respect of the period under review:            
First interim dividend 3,562 0.98 3,452 0.97 3,452 0.97
Second interim dividend - - - - 3,509 0.97
Third interim dividend - - - - 3,509 0.97
  8,808 2.43 8,613 2.42 15,631 4.36

                A second interim dividend in respect of the year ending 30 June 2017 of 0.98p per ordinary share was paid on 28 February 2017 to shareholders on the register on 27 January 2017. In accordance with International Financial Reporting Standards ('IFRS') this dividend has not been included as a liability in these accounts.

3.       Investment Gains

Included within gains on investments for the period ended 31 December 2016 are realised gains of £86,000 and unrealised gains of £9,936,000.

4.       Income

        The breakdown of income for the period was as follows:

  Six months ended 31 December 2016 Six months ended 31 December 2015         Year ended       30 June 2016
 
    £'000   £'000   £'000
Income from investments:            
Dividend income   865   800   1,471
Preference share income   581   1,110   1,180
Interest on fixed interest securities   8,631   7,954   16,041
Total income   10,077   9,864   18,692

                                                                                                 

  1. Investment Management Fee

The Company's investment manager is CQS which has delegated this function to NCIM.  The contract between the Company and CQS may be terminated by either party giving not less than 12 months' notice of termination.  CQS receive a basic monthly fee at the rate of 0.8 per cent per annum of the Company's total assets (less current liabilities other than bank borrowings), payable in arrears up to and including £200,000,000 and 0.7 per cent per annum above this.  During the period investment management fees of £905,528 were incurred, of which £151,295 were payable at the period end.

6.       Earnings per Ordinary Share

       The revenue earnings per ordinary share is based on the net profit after taxation of £8,803,000 (31 December 2015: £8,499,000 and 30 June 2016: £16,156,000) and on a weighted average of 363,161,029 (31 December 2015: 356,988,325 and 30 June 2016: 359,441,578) ordinary shares in issue throughout the period.

       The capital return per ordinary share is based on a net capital gain of £9,887,000 (31 December 2015: a net capital loss of £9,025,000 and 30 June 2016: a net capital loss of £14,808,000) and on a weighted average of 363,161,029 (31 December 2054: 356,988,325 and 30 June 2016: 359,441,578) ordinary shares in issue throughout the period.

7.       Bank Loan Facility

  December 2016 December 2015 June 2016
  £'000 £'000 £'000
Bank loan facility 25,000 25,000 25,000

The Company has a short term loan facility with Scotiabank. As at the period end the unsecured loan facility had a limit of £30 million of which £25 million was drawn down as at 31 December 2016.

  1. Stated Capital Account

Authorised The authorised share capital of the Company is represented by an unlimited number of ordinary shares of no par value.

Allotted, called up and fully-paid Number of  
  Ordinary shares £'000
Total issued share capital at 1 July 2016 361,774,417 154,397
1,750,000 ordinary shares of no par value issued on 9 August 2016 1,750,000 1,013
Total issued share capital at 31 December 2016 363,524,417 155,410

On 9 August 2016 the Company allotted 1,750,000 ordinary shares of no par value, issued from Treasury, for cash at 57.87p per share.

The balance of shares left in Treasury as at 31 December 2016 was 34,427,441.

9.       Net Asset Value per Ordinary share

       The net asset value per ordinary share is based on net assets at the period end of £208,722,000 (31 December 2015: £202,972,000 and 30 June 2016: £197,827,000) and on 363,524,417 (31 December 2015: 356,988,325 and 30 June 2016: 361,774,417) ordinary shares, being the number of ordinary shares in issue at the period end.

10.    Related Parties

The following are considered related parties: the Board of Directors ("the Board") and CQS/New City Investment Managers ("the Investment Manager").

All transactions with related parties are carried out on an arms length basis.

There are no other transactions with the Board other than aggregated remuneration for services as Directors.  There are no outstanding balances to the Board at the period end.

Details of the fee arrangement with the Investment Manager are disclosed in note 5.

                                                                            

  1. Financial Information

These are not statutory accounts in terms of Section 434 of the Companies Act 2006 and have not been audited or reviewed by the Company's auditors.  The information for the year ended 30 June 2016 has been extracted from the latest published financial statements which received an unqualified audit report and have been filed with the Registrar of Companies.  No statutory accounts in respect of any period after 30 June 2016 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

  1. The interim report for the six months ended 31 December 2016 will be posted to shareholders and made available on the website www.ncim.co.uk .  Copies may also be obtained from the Company's registered office, Ordnance House, 31 Pier Road, St. Helier, Jersey, JE4 8PW, Channel Islands.

Directors' Statement of Principal Risks and Uncertainties

The Company's assets consist principally of listed fixed interest securities and its principal risks are therefore market related.  The Company is also exposed to currency risk in respect of the markets in which it invests. Other key risks faced by the Company relate to investment and strategy, market, financial, earnings and dividend, operational and regulatory matters.  These risks, and the way in which they are managed, are described in more detail under the heading 'Principal risks and risk management' within the Directors' Report and Business Review contained within the Company's annual report and accounts for the year ended 30 June 2016.  The Company's principal risks and uncertainties have not changed materially since the date of that report and are not expected to change materially for the rest of the Company's financial year.

Directors' Responsibility Statement in Respect of the Interim Report

We confirm that to the best of our knowledge:

· the condensed set of financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the EU and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company;

· the Chairman's Statement and Investment Manager's Review includes a fair review of the information required by the Disclosure Guidance and Transparency Rules ('DTR') 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the financial statements;

· the Directors' Statement of Principal Risks and Uncertainties shown above is a fair review of the information required by DTR 4.2.7R; and

· the condensed set of financial statements include a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the financial year and that have materially affected the financial position or performance of the Company during that period, and any changes in the related party transactions described in the last Annual Report that could do so.

On behalf of the Board

J G West Chairman

3 March 2017

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Enanta Pharmaceuticals Highlights Fiscal Q1 2025 Performance

Updated Category News Views 188

Enanta Pharmaceuticals Reports Financial Highlights for Q1 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology firm, has revealed its financial results for the first fiscal quarter ending December 31, 2024. This quarter is seen as a crucial period for the company as it expands its innovative drug portfolio targeting viral and immunological...

Continue Reading
Friedman Industries Reports Impressive First Quarter Growth

Updated Category News Views 98

Friedman Industries Reports Significant First Quarter Growth Friedman Industries, Incorporated (NASDAQ/GS: FRD) has announced remarkable results for the first quarter of the fiscal year, showcasing a strong performance that has positioned the company favorably in the steel manufacturing sector. The results released highlight not only the growth in earnings but also an...

Continue Reading
From Doubt to Delicious: The Rise of Raising Cane's

Updated Category News Views 308

Overcoming Doubt: The Birth of Raising Cane's The journey of Raising Cane's is not just about chicken fingers; it's a story of perseverance. Founded by Todd Graves, the chain has become a testament to how challenges can fuel passion and success. Graves faced significant skepticism from those who thought the concept was flawed due to its limited menu. Motivation Behind...

Continue Reading
Understanding Japan's Impact on US Tech Stock Dynamics

Updated Category News Views 371

The Influence of Japan's Real Rates on US Markets The current landscape of the S&P 500 bull market has been subject to various influences, and surprisingly, one of the most significant factors is not a domestic recession in the US but rather Japan's extraordinarily negative real interest rates compared to those in the US. This insightful perspective comes from BCA...

Continue Reading
Ocean Ledger Secures Funding to Enhance Coastal Risk Solutions

Updated Category News Views 171

Ocean Ledger Secures Funding for Coastal Risk Management Ocean Ledger, a promising geospatial analytics startup, has recently completed a successful funding round, securing $900K to enhance its capabilities in coastal risk management. This investment is poised to support the development of innovative solutions aimed at forecasting coastal risks, benefitting various...

Continue Reading